Jade Biosciences Inc. (AVTE)
NASDAQ · Healthcare
Jade Biosciences Inc. Total Liabilities 2019–2024
Jade Biosciences Inc. annual total liabilities history from 2019 to 2024. Total liabilities is the combined debt and financial obligations a company owes to creditors.
- Jade Biosciences Inc. total liabilities as of December 31, 2024: 3.9M, a 78.30% decrease year-over-year.
- Jade Biosciences Inc. total liabilities for 2024 were 3.9M, a 78.30% decrease from 2023.
- Jade Biosciences Inc. total liabilities for 2023 were 18.0M, a 109.89% increase from 2022.
- Jade Biosciences Inc. total liabilities for 2022 were 8.6M, a 190.59% increase from 2021.
- Jade Biosciences Inc. total liabilities for 2021 were 2.9M.
Total Liabilities
ANNUAL · $B
YEAR-OVER-YEAR GROWTH · %
| Jade Biosciences Inc. Annual Total Liabilities (Millions of US $) | |
|---|---|
| 2024 | $4 |
| 2023 | $18 |
| 2022 | $9 |
| 2021 | $3 |
| 2020 | $18 |
| 2019 | $7 |
Jade Biosciences Inc. Total Liabilities — FAQ
Jade Biosciences Inc. (AVTE) total liabilities over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see AVTE's total liabilities history?
The chart and table above show Jade Biosciences Inc.'s total liabilities by year and by quarter, including the growth rate.